WALTHAM, Mass., Dec. 12 /PRNewswire/ -- Millennium Research Group (MRG) analyst Deanna Vankessel, author of the recently published Global Markets for Hyaluronic Acid Viscosupplementation 2008 report, is available to offer extensive expertise on the recent FDA premarket approval recommendation of Genzyme Biosurgery's Synvisc single-injection product for osteoarthritis of the knee.
MRG's Deanna Vankessel is available to comment on:
MRG's global hyaluronic acid viscosupplementation expertise covers the US, Europe (Austria, France, Germany, Italy, Spain, and the UK), and Japan.
To arrange an interview with Deanna Vankessel, please contact Amy Krohn at 416-364-7776 ext. 101 or email@example.com.
About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResources.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through published reports, ongoing Marketrack(TM) projects, and customized solutions.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com .
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact: Amy Krohn Millennium Research Group 416-364-7776 x101 firstname.lastname@example.org Elizabeth Marshall Decision Resources Inc. 781-296-2563 email@example.com
|SOURCE Millennium Research Group|
Copyright©2008 PR Newswire.
All rights reserved